Skip to content

Clinical trials

Active, not recruiting Phase 2 Myelodysplastic Syndromes trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Phase 2 Status: Active, not recruiting Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20111
20122
20142
20152
20162
20172
20181
20196
20202
20215
20224
20237
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting38

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
City of Hope Medical Center6
M.D. Anderson Cancer Center4
National Cancer Institute (NCI)4
St. Jude Children's Research Hospital4
Memorial Sloan Kettering Cancer Center3
Center for International Blood and Marrow Transplant Research2
Groupe Francophone des Myelodysplasies2
Novartis Pharmaceuticals2
Agios Pharmaceuticals, Inc.1
Asan Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes38
Leukemia, Myeloid, Acute21
Precursor Cell Lymphoblastic Leukemia-Lymphoma14
Leukemia, Myelomonocytic, Chronic9
Myeloproliferative Disorders9
Lymphoma, Non-Hodgkin7
Hodgkin Disease6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive6
Leukemia5
Leukemia, Lymphocytic, Chronic, B-Cell5

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.